Ignite Creation Date:
2024-05-06 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03522298
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2018-03-20
Brief Title:
Safety Pharmacokinetics and Efficacy of Paxalisib GDC-0084 in Newly-diagnosed Glioblastoma
Sponsor:
Kazia Therapeutics Limited
Organization:
Kazia Therapeutics Limited
Organization Data
Organization:
Kazia Therapeutics Limited
Class:
INDUSTRY
Study ID:
NVGN-0084-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kazia Therapeutics Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None